Sort
51,593 grants matching “hepatitis”
Project 2: Nuclear Receptor Mediated Epigenetic and Immune Cell Changes in Liver Fibrosis Resulting From Toxicant Exposure
$392,212Ronald M. Evans · University Of California, San Diego · P42 · FY2021 · ES
Hepatitis B treatment and HIV Infection in resources limited settings
$392,200Chloe L Thio · Johns Hopkins University · R01 · FY2008 · AI
Pharmacogenetics of ADRs: Warfarin Toxicity
$392,185Allan Edward Rettie · University Of Washington · R01 · FY2010 · GM
HAART optimism, drug use and risky sexual behavior among MSM in British Columbia.
$392,120Robert S Hogg · Simon Fraser University · R01 · FY2015 · DA
CORE--LABORATORY ANIMAL FACILITY
$392,118Robert C Young · Fox Chase Cancer Center · P30 · FY2007 · CA
Role of HCV in aberrant APC activation/function
$392,100Young S. Hahn · University Of Virginia · R01 · FY2012 · AI
Role of HCV in aberrant APC activation/function
$392,100Young S. Hahn · University Of Virginia · R01 · FY2014 · AI
Role of HCV in aberrant APC activation/function
$392,100Young S. Hahn · University Of Virginia · R01 · FY2016 · AI
Role of HCV in aberrant APC activation/function
$392,100Young S. Hahn · University Of Virginia · R01 · FY2015 · AI
Hepatitis C and Alcohol Study
$392,065University Of California San Francisco · M01 · FY2004 · RR
Interrogation of novel pathways regulating VLDL production and plasma lipids
$392,000Daniel James Rader · University Of Pennsylvania · R01 · FY2014 · HL
Modulation of Acute Liver Injury
$391,942Mark J. Czaja · Albert Einstein College Of Medicine · R01 · FY2014 · DK
Modulation of Acute Liver Injury
$391,942Mark J. Czaja · Albert Einstein College Of Medicine · R01 · FY2012 · DK
Novel Approaches to Understanding the Nutrient Regulation of Fetal Somatic Growth
$391,941Philip A. Gruppuso · Rhode Island Hospital · R01 · FY2014 · HD
The role of neutralizing antibodies in natural and treatment-induced control of hepatitis B with and without HIV-1 co-infection
$391,926Justin Richard Bailey · Johns Hopkins University · R01 · FY2024 · AI
Lipid transport in the intestine
$391,908Judith Storch · Rutgers, The State Univ Of N.J. · R01 · FY2017 · DK
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
$391,875Cheng Ji · University Of Southern California · R01 · FY2023 · DA
Structure and Function of the Hepatitis C Virus Genome
$391,875Stanford University · R01 · FY2005 · AI
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
$391,875Cheng Ji · University Of Southern California · R01 · FY2024 · DA
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
$391,875Cheng Ji · University Of Southern California · R01 · FY2025 · DA
Portable Nanostructured Photonic Crystal Device for HIV-1 Viral Load
$391,872Utkan Demirci · Stanford University · R01 · FY2016 · AI
Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV
$391,834Susanna Naggie · Duke University · R01 · FY2020 · DK
Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV
$391,834Susanna Naggie · Duke University · R01 · FY2019 · DK
Identification of Novel Bioactive Lipid Metabolites for Predicting Liver-related Outcomes in Persons Co-Infected with HIV and HCV
$391,834Susanna Naggie · Duke University · R01 · FY2021 · DK
Role of HBx Protein in HBV Replication
$391,826New York University School Of Medicine · R01 · FY2002 · CA